ICEC carries out its mission through a global mentoring network of dedicated active and retired expert cancer professionals in resource-rich settings, representing a broad spectrum of expertise from academia, private practice, government and industry. These individuals partner with professionals in resource-poor countries to improve cancer prevention, screening, diagnosis, treatment and follow-up care in those countries.

ICEC also supports Young Investigators who also provide innovative and sustainable training and mentoring of ICEC Associates in resource-poor settings to help them achieve resource-appropriate education and training and multimodality cancer care using guideline- and protocol-based treatments. The efforts of these Young Investigators and issues pertinent to a career path in Global Cancer were featured in this ICEC Young Investigators’ Conference. Links to all of the sessions will be made available in the near future.

AGENDA

Faculty and participants considered the following topics:

8:00 – 9:00 AM: Registration/Coffee
9:00 – 9:10 AM:  Welcome/Introduction
Onyinye Balogun, MD, Weill Cornell Medicine
John (Mac) Longo, MD, Medical College of Wisconsin

9:10 – 9:30 AM: “Why global oncology matters?”

C. Norman Coleman, MD
Associate Director, Radiation Research Program
Division of Cancer Treatment and Diagnosis (DCTD)
National Cancer Institute (NCI) – confirmed

9:30 – 10:30 AM:  Why is Global Oncology Important? Local Global Oncology – Addressing the needs of the underserved locally
Moderator:  Tracy Sherertz, MD
Kaiser, Capitol Hill, Washington

The panel discussed “Local-Global” Oncology: how approaches in the care of oncology patients worldwide are more alike than different. Prominent experts in local-global health will describe the benefits gained and lessons learned through global oncology efforts when applied to local populations in resource-rich countries who experience disparities similar to those found in LMICs. Examples will be presented as to how “Global Oncology” efforts directly impact work in the US and other resource-rich countries. This session will include perspectives from the fields of Medical Oncology/Surgical Oncology/Gynecologic and Oncology/Radiation Oncology.

Jean-Marc Bourque, MD 
Institute of Cancer Policy
Kings Health Partners Integrated Cancer Centre
Kings College London

 Ashleigh Guadagnolo, MD, MPH
Professor, Department of Radiation Oncology, Division of Radiation Oncology
Professor, Department of Health Services Research, Division of OVP, Cancer Prevention and Population Sciences
The University of Texas MD Anderson Cancer Center

10:30 – 11:00 AM: COFFEE BREAK

11:00 – 12:00 PM: Global Oncology Policy Perspectives
Moderator:  Danielle Rodin, MD, MPH, FRCPC
University of Toronto

This session explored how global oncology policy is shaped from a variety of perspectives including those of non-governmental organizations, professional societies, the United Nations and the World Health Organization, patient advocacy groups and local disparities efforts.

Non-governmental organizations
Patrick Loehrer, MD  
Indiana University Distinguished Professor
Associate Dean for Cancer Research, IU School of Medicine
Director, Indiana University Melvin and Bren Simon Cancer Center
HH Gregg Professor of Oncology, IU School of Medicine
Professor of Medicine, IU School of Medicine
Co-founder, Academic Model Providing Access to Healthcare (AMPATH) Oncology Institute

Professional societies
Yolande Lievens, MD, PhD 
Chair, Radiation Oncology Institute
Ghent University – Belgium
ESTRO – Past President 

Ntokozo Ndlovu, MD 
Clinical Epidemiologist University of Zimbabwe College of Health Sciences
Harare, Zimbabwe
AORTIC Education Committee

 Joel Yarney, MD
Consultant Oncologist and Director National Centre for Radiotherapy Oncology and Nuclear Medicine
Korle Bu Teaching Hospital
Adjunct lecturer School of Medicine and Dentistry University of Ghana

United Nations/WHO
André Ilbawi, MD 
Fellow, Complex Surgical Oncology
M.D. Anderson Cancer Center, Houston, TX
Technical Officer, WHO Department for Management of Noncommunicable Diseases, Disability, Violence and Injury Prevention (NVI)

Kirsten Hopkins, MD  
Division of Human Health
International Atomic Energy Agency
Vienna, Austria

12:00 – 1:00 PM: Lunch/Networking

1:00 – 5:00 PM: Building Ethical, Mutually Beneficial Global Oncology Partnerships: Models of academic global oncology career paths.
The session will illustrate how international twinning programs provide high-quality education and training to grow workforce capacity and capability through mentoring relationships. Successful models of global oncology including clinical research, basic research, and building capacity for education and training will be presented.

Moderator: Hon. Keith Martin, MD, PC
Executive Director
Consortium of Universities for Global Health

John “Mac” Longo
Medical College of Wisconsin

1:00 – 1:50 PM General Aspects of Relationships/Partnerships: The importance of building ethical partnerships

Rebecca (Becky) DeBoer, MD, MA
Global Health Hospital Medicine Fellow
University of Chicago

Dr. Cyprien Shyirambere
Director of Oncology
Partners In Health/Inshuti Mu Buzima
Kigali, Rwanda

1:50-2:40 PM Basic Science Partnerships

Lisa A. Newman, MD, MPH, FACS, FASCO
Weill Cornell Medicine-New York Presbyterian Hospital Network
Chief, Division of Breast Surgery and Director, Interdisciplinary Breast Disease Program
Founding Medical Director, International Center for the Study of Breast Cancer Subtypes
Adjunct Professor, M.D. Anderson Cancer Center
Adjunct Professor, University of Michigan

Patrick Loehrer, MD
Indiana University Distinguished Professor
Associate Dean for Cancer Research, IU School of Medicine
Director, Indiana University Melvin and Bren Simon Cancer Center
HH Gregg Professor of Oncology, IU School of Medicine
Professor of Medicine, IU School of Medicine
Co-founder, Academic Model Providing Access to Healthcare (AMPATH) Oncology Institute

Melissa Boneta Davis, PhD
Assistant Professor of Cell and Developmental Biology Research in Surgery
Weill Cornell Medicine

2:40-3:10 PM BREAK

3:10-4:00 PM Clinical Research Partnerships

T. Peter Kingham, MD, FACS
Director of Global Cancer Disparity Initiatives
Memorial Sloan Kettering Cancer Center

Ntokozo Ndlovu, MD
Clinical Epidemiologist University of Zimbabwe College of Health Sciences
Harare, Zimbabwe
AORTIC Education Committee

4:00-5:00 PM Capacity Building and Educational Partnerships

Achille Manirakiza, MD
Clinical & Radiation Oncologist
Department of Radiation Oncology
Rwanda Military Hospital

Thomas Samuel Ram, MD
Christian Medical College
Vellore, India

Joel Yarney, MD
Consultant Oncologist and Director National Centre for Radiotherapy Oncology and Nuclear Medicine
Korle Bu Teaching Hospital
Adjunct lecturer School of Medicine and Dentistry University of Ghana

5:00 – 6:30 PM: Reception and Selected Poster Presentations

The International Cancer Expert Corps invited reports on original research, innovative projects, and novel programs related to global oncology to be considered for presentation at the conference. Authors of the top 3 Abstracts selected by the Abstract Review Committee presented their posters orally in the Great Hall on Thursday, February 14, 2019, at 5:00 p.m.  All other posters were on display for the duration of the conference.

Friday, February 15th, 2019

8:00 – 8:30 AM: Coffee/Networking
8:30 – 8:35 AM: Introduction of keynote speaker
Onyinye Balogun, MD & John (Mac) Longo, MD

8:40 – 9:30 AM:   Keynote Address

Douglas R. Lowy, MD
Deputy Director
National Cancer Institute (NCI) – Confirmed

 9:30 – 10:00 AM: COFFEE BREAK

10:00 – 12:00 PM:  Career Development in Global Oncology: Expectations, opportunities and solutions

In the absence of a defined path to pursue an academic (or private practice) career in global oncology, interns, residents, fellows and junior attendings, often face challenges in designing a career path in global oncology. The challenges faced by these young investigators and their international colleagues as well as those faced by department chairs in balancing the demands of running a department while providing professional opportunities, especially in global oncology, within the boundaries of a medical program were presented.

10:00 – 11:00 AM: Perspective of Young Investigators
Moderator: Harmar D. Brereton, MD
Weill Cornell Medicine 

Shekinah N. Elmore, MD, MPH
Resident
Harvard Radiation Oncology Program
Holman Pathway Candidate 

Fidel Rubagumya, MD 
Clinical Oncology
Ocean Road Cancer Institute
University of Health and Allied Sciences, Tanzania
Founder at Rwanda Children’s Cancer Relief 

Surbhi Grover, MD, MPH
Assistant Professor of Radiation Oncology at the Hospital of the University of Pennsylvania
Radiation Oncology Department
Botswana-UPENN partnership, Princess Marina Hospital, Gaborone, Botswana 

Kristin Schroeder, MD MPH
Assistant Professor, Pediatric Hematology and Oncology,
Assistant Research Professor, Duke Global Health Institute
Bugando Medical Centre, Duke Global Cancer Program, Mwanza, Tanzania

Brandon Fisher, MD
Co-founder and past president of Radiating Hope
Gamma West Cancer Services
Salt Lake City, Utah 

11:00 – 12:00 PM: Perspective of Senior Mentors and Chairs/Directors
Moderator: Chika Nwachukwu, MD, PhD
Stanford University

Silvia Chiara Formenti, MD 
Chair of Radiation Oncology at Weill Cornell Medical College
Radiation Oncologist-in-Chief at New York-Presbyterian/Weill Cornell Medical Center
Sandra and Edward Meyer Professor of Cancer Research

Rebecca Wong, MBChB, FRCPC, MSc
Vice Chair, Education, Department of Radiation Oncology, University of Toronto
Radiation Medicine Program, University Health Network, Princess Margaret Cancer Centre

James M. Metz, MD
Professor and Chair
Radiation Oncology
Executive Director, OncoLink
Hospital of the University of Pennsylvania
Perelman Center for Advanced Medicine

Satish Gopal, MD, MPH
Associate Professor of Medicine, University of North Carolina
Associate Professor of Epidemiology, Gillings School of Global Public Health
Cancer Program Director, UNC Project-Malawi

James Cleary, MD, PhD
Director, Walther Supportive Oncology Program
Indiana University School of Medicine

Aziza T. Shad, MD
Ellen Wasserman Chair of Pediatrics
Chief, Pediatric Hematology Oncology
Herman and Walter Samuelson Children’s Hospital at Sinai
Professor of Pediatrics & Oncology
Georgetown University School of Medicine 

12:00 – 1:00 PM: Lunch/Networking

1:00 – 2:30 PM: Breakout sessions
1st round/2 groups 1:00-1:40 20 minutes each

10-minute break
2nd round/2 groups 1:50-2:30 20 minutes each

 2:30 PM – 2:45 PM: Summary session of “Breakouts” key points

 2:45-3:00 PM: Closing Remarks and Next Steps (leadership team):

By 2020, nearly 70% of the world’s total of 20 million new cancer cases will occur in developing countries. Because of shortages in the cancer professional workforce in LMICs have reached critical levels, there is an urgent need to train oncologists in global cancer care to work with colleagues in LMICs to develop sustainable capability and capacity as well as to enhance the physical infrastructure for clinical oncology care, research and education. This summary session addressed what’s next, including the potential benefits that international twinning programs and mentoring relationships bring to countries and regions with inadequate resources and limited availability of highly trained and experienced health care practitioners. It also highlighted the roles and potential that healthcare professionals, patient advocates and sponsors including academia, industry, business and governments can play in supporting international twinning programs and the careers of professionals dedicated to global oncology. These discussions will set the agenda for the next Young Investigators’ Conference.

3:00 PM Conference Adjourns